SKYSTAR BIO-PHARMACEUTICAL CO: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2013)
- $42.5M
- Net Income/Loss (FY2013)
- $10.5M
- Total Assets (FY2013)
- $136.2M
- Total Equity (FY2013)
- $110.4M
- Cash Flows from Operating Activities (FY2013)
- -$5.4M
Source: SKYSTAR BIO-PHARMACEUTICAL CO 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
